Wells Fargo’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $955K | Sell |
112,766
-142,456
| -56% | -$1.36M | ﹤0.01% | 3757 |
|
|
2025
Q4 | $3.1M | Buy |
255,222
+124,370
| +95% | +$1.51M | ﹤0.01% | 3086 |
|
|
2025
Q3 | $1.53M | Buy |
130,852
+56,702
| +76% | +$678K | ﹤0.01% | 3509 |
|
|
2025
Q2 | $688K | Sell |
74,150
-2,895
| -4% | -$22.7K | ﹤0.01% | 3933 |
|
|
2025
Q1 | $565K | Buy |
77,045
+2,837
| +4% | +$21.8K | ﹤0.01% | 4011 |
|
|
2024
Q4 | $634K | Sell |
74,208
-382,218
| -84% | -$3.73M | ﹤0.01% | 4024 |
|
|
2024
Q3 | $3.97M | Buy |
456,426
+405,107
| +789% | +$3.34M | ﹤0.01% | 2535 |
|
|
2024
Q2 | $351K | Buy |
51,319
+15,280
| +42% | +$94.3K | ﹤0.01% | 4136 |
|
|
2024
Q1 | $328K | Buy |
36,039
+13,836
| +62% | +$98.2K | ﹤0.01% | 4168 |
|
|
2023
Q4 | $99K | Buy |
22,203
+5,078
| +30% | +$15K | ﹤0.01% | 4908 |
|
|
2023
Q3 | $53.8K | Sell |
17,125
-17,388
| -50% | -$71.2K | ﹤0.01% | 5139 |
|
|
2023
Q2 | $178K | Buy |
34,513
+16,724
| +94% | +$99.5K | ﹤0.01% | 4647 |
|
|
2023
Q1 | $93.7K | Buy |
17,789
+15,839
| +812% | +$75.2K | ﹤0.01% | 4837 |
|
|
2022
Q4 | $5.48K | Sell |
1,950
-4,562
| -70% | -$15.1K | ﹤0.01% | 5740 |
|
|
2022
Q3 | $27K | Sell |
6,512
-605
| -9% | -$3.05K | ﹤0.01% | 5256 |
|
|
2022
Q2 | $29K | Sell |
7,117
-9,103
| -56% | -$34.4K | ﹤0.01% | 5275 |
|
|
2022
Q1 | $80K | Sell |
16,220
-25,816
| -61% | -$143K | ﹤0.01% | 5430 |
|
|
2021
Q4 | $292K | Sell |
42,036
-14,450
| -26% | -$112K | ﹤0.01% | 5055 |
|
|
2021
Q3 | $565K | Sell |
56,486
-15,825
| -22% | -$178K | ﹤0.01% | 4599 |
|
|
2021
Q2 | $1.02M | Sell |
72,311
-463,021
| -86% | -$7.04M | ﹤0.01% | 4200 |
|
|
2021
Q1 | $8.79M | Buy |
535,332
+232,689
| +77% | +$4.48M | ﹤0.01% | 2310 |
|
|
2020
Q4 | $6.26M | Buy |
302,643
+135,832
| +81% | +$2.02M | ﹤0.01% | 2519 |
|
|
2020
Q3 | $1.27M | Buy |
166,811
+98,612
| +145% | +$818K | ﹤0.01% | 3677 |
|
|
2020
Q2 | $568K | Buy |
68,199
+15,271
| +29% | +$101K | ﹤0.01% | 4233 |
|
|
2020
Q1 | $262K | Sell |
52,928
-1,858
| -3% | -$9.17K | ﹤0.01% | 4496 |
|
|
2019
Q4 | $216K | Sell |
54,786
-293
| -0.5% | -$1.02K | ﹤0.01% | 4907 |
|
|
2019
Q3 | $168K | Buy |
55,079
+24,254
| +79% | +$108K | ﹤0.01% | 5065 |
|
|
2019
Q2 | $136K | Sell |
30,825
-2,936
| -9% | -$10.9K | ﹤0.01% | 5169 |
|
|
2019
Q1 | $134K | Sell |
33,761
-46
| -0.1% | -$185 | ﹤0.01% | 5020 |
|
|
2018
Q4 | $134K | Sell |
33,807
-11,239
| -25% | -$61.9K | ﹤0.01% | 5144 |
|
|
2018
Q3 | $310K | Buy |
45,046
+12,170
| +37% | +$76.4K | ﹤0.01% | 4760 |
|
|
2018
Q2 | $222K | Sell |
32,876
-607
| -2% | -$4.17K | ﹤0.01% | 4968 |
|
|
2018
Q1 | $218K | Sell |
33,483
-33,116
| -50% | -$186K | ﹤0.01% | 4944 |
|
|
2017
Q4 | $296K | Sell |
66,599
-8,402
| -11% | -$42.9K | ﹤0.01% | 4760 |
|
|
2017
Q3 | $463K | Sell |
75,001
-649
| -0.9% | -$4.18K | ﹤0.01% | 4380 |
|
|
2017
Q2 | $701K | Sell |
75,650
-11,396
| -13% | -$110K | ﹤0.01% | 3995 |
|
|
2017
Q1 | $807K | Buy |
87,046
+17,445
| +25% | +$145K | ﹤0.01% | 3906 |
|
|
2016
Q4 | $582K | Buy |
69,601
+30,921
| +80% | +$240K | ﹤0.01% | 4091 |
|
|
2016
Q3 | $266K | Buy |
38,680
+752
| +2% | +$4.58K | ﹤0.01% | 4313 |
|
|
2016
Q2 | $188K | Sell |
37,928
-6,425
| -14% | -$63.7K | ﹤0.01% | 4442 |
|
|
2016
Q1 | $429K | Buy |
44,353
+22,360
| +102% | +$169K | ﹤0.01% | 3955 |
|
|
2015
Q4 | $206K | Buy |
21,993
+539
| +3% | +$5.82K | ﹤0.01% | 4439 |
|
|
2015
Q3 | $302K | Buy |
21,454
+5,263
| +33% | +$106K | ﹤0.01% | 4239 |
|
|
2015
Q2 | $340K | Buy |
16,191
+10,299
| +175% | +$255K | ﹤0.01% | 4298 |
|
|
2015
Q1 | $247K | Buy |
5,892
+5,625
| +2,107% | +$185K | ﹤0.01% | 4327 |
|
|
2014
Q4 | $6K | Buy |
+267
| New | +$4.49K | ﹤0.01% | 5808 |
|
Other funds holding OCUL
DTC
ACA
SR
VA
VCM
